Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Teriflunomide added to interferon-β in relapsing multiple sclerosis: A randomized phase II trial.
MS Research Roundup: January 29, 2014
Relapses Requiring Intravenous Steroid Use and Multiple-Sclerosis-Related Hospitalizations: Integrated Analysis of the Delayed-Release Dimethyl Fumarate Phase III Studies.
MHC transmission: insights into gender bias in MS susceptibility.
Testosterone treatment in multiple sclerosis: a pilot study.
Transfer of interferon β-1a into human breastmilk.
MS Research Roundup: January 31, 2014
Cognitive Test Analysis May Determine Reliable MS Change Over Time
Gene expression in brain during cuprizone-induced demyelination and remyelination.
Episode 27 with Dr. Brenda Banwell on the new journal Multiple Sclerosis and Related Disorders
Teriflunomide modest help but safe for MS
EAE: an immunologist's magic eye.
Multiple sclerosis in Hispanics: a study of clinical disease expression.
Efficacy of flupirtine on cognitive function in patients with CJD: A double-blind study.
Scientific discussion for the approval of Masivet
Integrating Acupuncture Within a Wellness Intervention for Women With Multiple Sclerosis: A Feasibility Study.
Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC) and the Cooperative Meeting with Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)
US patent office grants patent claiming dosing regimen for TECFIDERA™ (dimethyl fumarate)
Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study.
Spotlight on teriflunomide.
Episode 23 with Professor Aksel Siva discussing radiologically isolated syndrome (RIS)
Long-Term Effects of Exposure to Disease-Modifying Drugs in the Offspring of Mothers with Multiple Sclerosis: A Retrospective Chart Review.
An older dog with newer tricks: Predicting efficacy of IFN-β treatment for multiple sclerosis.
The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis.
Blood Brain Barrier Meeting

Pages